These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26891055)

  • 1. Short versus long gonadotropin-releasing hormone analogue suppression protocols in advanced age women undergoing IVF/ICSI.
    Ou J; Xing W; Li T; Li Y; Xu Y; Zhou C
    Gynecol Endocrinol; 2016 Aug; 32(8):622-624. PubMed ID: 26891055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges.
    Ou J; Xing W; Li Y; Xu Y; Zhou C
    PLoS One; 2015; 10(7):e0133887. PubMed ID: 26208150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.
    Lan J; Wu Y; Wu Z; Wu Y; Yang R; Liu Y; Lin H; Jiao X; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():609771. PubMed ID: 34135858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative prospective study of 2 ovarian stimulation protocols in poor responders: effect on implantation rate and ongoing pregnancy.
    Merviel P; Cabry-Goubet R; Lourdel E; Devaux A; Belhadri-Mansouri N; Copin H; Benkhalifa M
    Reprod Health; 2015 May; 12():52. PubMed ID: 26025412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature Progesterone Elevation Does Not Affect Pregnancy Outcome in High-Responder Patients Undergoing Short-Interval Coasting in IVF Cycles.
    Acet M; Aktün LH; Başaranoğlu S; Yorgunlar B; Acet T; Deregözü A
    Med Sci Monit Basic Res; 2015 Nov; 21():247-52. PubMed ID: 26634938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of IVF/ICSI Cycles: A retrospective study.
    Duan L; Bao S; Li K; Teng X; Hong L; Zhao X
    J Obstet Gynaecol Res; 2017 Jun; 43(6):1037-1042. PubMed ID: 28422380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
    Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
    Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of triploidy incidence on clinical outcomes for IVF-ET cycles in different ovarian stimulation protocols.
    Li M; Xue X; Zhang S; Li W; Zhao X; Ren W; Shi J
    Gynecol Endocrinol; 2015 Oct; 31(10):769-73. PubMed ID: 26220642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between "short" and "long" protocols in an ICSI programme.
    Loutradis D; Stefanidis K; Drakakis P; El Sheikh A; Milingos S; Antsaklis A; Michalas S
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):69-72. PubMed ID: 15866089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of normal sperm morphology rate (NSMR) on clinical outcomes and fertilization methods selection in the ultra-short-term GnRH-a protocol.
    Li M; Ma C; Xue X; Zhao W; Zhang S; Shi J
    Gynecol Endocrinol; 2016; 32(2):120-3. PubMed ID: 26437674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
    Xing W; Lin H; Li Y; Yang D; Wang W; Zhang Q
    PLoS One; 2015; 10(10):e0140286. PubMed ID: 26468951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.